SynthesisFrontiers in immunology2022

Evaluation of anifrolumab safety in systemic lupus erythematosus: A meta-analysis and systematic review.

Zhihui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.